Fingerprint
Dive into the research topics of 'A randomized, double-blind, placebo-controlled phase II study of the efficacy and safety of monotherapy ontuxizumab (MORAb-004) plus best supportive care in patients with chemorefractory metastatic colorectal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically